MESSIAEN, Peter

Email Alert RSS Feed

Profile

Full Name
MESSIAEN, Peter
Email
peter.messiaen@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Refined By:
Date Issued:  2023

Results 1-9 of 9 (Search time: 0.004 seconds).

Issue DateTitleContributor(s)TypeCat.
12023Efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide for the treatment of HIV in a real-world setting in BelgiumNasreddine, Rakan; Florence, Eric; Yombi, Jean Cyr; Henrard, Sophie; Darcis, Gilles; Van Praet, Jens; Vandekerckhove, Linos D.; Allard, Sabine; Demeester, Remy; MESSIAEN, Peter; Ausselet, Nathalie; Delforge, Marc; De Wit, StephaneJournal ContributionA1
22023Efficacy, durability, and tolerability of dolutegravir/lamivudine and dolutegravir/rilpivirine for the treatment of HIV in a real-world setting in BelgiumNasreddine, Rakan; Yombi, Jean Cyr; Darcis, Gilles; Florence, Eric; Allard, Sabine D.; De Scheerder, Marie-Angelique; Henrard, Sophie; Demeester , Remy; MESSIAEN, Peter; Ausselet, Nathalie; Loeckx, Matthias; Delforge, Marc; De Wit, StephaneJournal ContributionA1
32023Dynamics of Weight Change After Initiation of Contemporaneous Antiretroviral Therapy in Treatment-Naive HIV-1 Infected Patients: Results From the Belgian HIV Cohort 2015-2021Van Praet, Jens T.; Serrien, Ben; Ausselet, Nathalie; Darcis, Gilles; Demeester, Remy; De Munter, Paul; De Scheerder, Marie-Angelique; Goffard, Jean-Christophe; Libois, Agnes; MESSIAEN, Peter; Yombi, Jean Cyr; Van Beckhoven, Dominique; Belgian HIV Cohort Study GrpJournal ContributionA1
42023Factors Associated with Health Care Providers' Preference for Forgoing an Oral Lead-In Phase When Initiating Long-Acting Injectable Cabotegravir and Rilpivirine in the SOLAR Clinical TrialKarver, Tahilin Sanchez; Pascual-Bernaldez, Miguel; Berni, Alessandro; Hnoosh, Ahmed; Castagna, Antonella; MESSIAEN, Peter; Puerto, Maria Jose Galindo; Bloch, Mark; Adachi, Eisuke; Sinclair, Gary; Felizarta, Franco; Angel, Jonathan B.; Sutton, Kenneth; Sutherland-Phillips, Denise; D'Amico, Ronald; Kerrigan, DeannaJournal ContributionA1
52023Comprehensive antibody and cytokine profiling in hospitalized COVID-19 patients in relation to clinical outcomes in a large Belgian cohortRUYTINX, Pieter; VANDORMAEL, Patrick; FRAUSSEN, Judith; PIETERS, Zoe; Thonissen, Stef; HELLINGS, Niels; STINISSEN, Piet; CALLEBAUT, Ina; PENDERS, Joris; VANHOVE, Karolien; Kieffer, Davy; RUMMENS, Jean-Luc; Valkenborgh, Tom; MESSIAEN, Peter; STESSEL, Bjorn; MESOTTEN, Dieter; SOMERS, VeerleJournal ContributionA1
62023Virulence Factor Genes in Invasive Escherichia coli Are Associated with Clinical Outcomes and Disease Severity in Patients with Sepsis: A Prospective Observational Cohort StudyD'ONOFRIO, Valentino; Cartuyvels, Reinoud; MESSIAEN, Peter; Barisic, Ivan; GYSSENS, IngeJournal ContributionA1
72023SOLAR 12-month European results: Randomized switch trial of CAB plus RPV vs. oral BIC/FTC/TAFDe Los Santos Gil, I.; Ustianowski, A.; Orofino, G.; Scholten, S.; MESSIAEN, Peter; Maggiolo, F.; Braun, D.; Wyen, C.; Demeester, R.; Jacomet, C.; Cua, E.; Calmy, A.; Clarke, E.; Sarcletti, M.; Dakhia, S.; Sutton, K.; Sutherland-Phillips, D.; Latham, C. L.; Berni, A.; Urbaityte, R.; Pascual-Bernaldez, M.; Ngenzi, B.; Schroeder, M.; Van Solingen-Ristea, R.; Baugh, B.; D'Amico, R.; Van Wyk, J.Journal ContributionM
82023Subjective sleep quality evolution in patients starting or switching to dolutegravir or cabotegravir: A real-world longitudinal studyMESSIAEN, Peter; Van Steenkiste, E.; Reumers, J.; COX, Janneke; van Halem, K.; VAN DER HILST, JeroenJournal ContributionM
92023Continuum of HIV care by key populations in Belgium: Cross-sectional and longitudinal viewsVan Beckhoven, D.; Serrien, B.; Darcis, G.; Demeester, R.; De Munter, P.; Henrard, S.; Libois, A.; MESSIAEN, Peter; Van Praet, J.; Macq, J.Journal ContributionM